Yulin Zhu, Lingti Kong, Shan Gao, Yong Zhang
Department of Pharmacy, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Saudi Pharm J. 2020 Nov;28(11):1408-1410. doi: 10.1016/j.jsps.2020.09.005. Epub 2020 Sep 14.
Drug-drug interactions lead to altered clinical effects, including adverse reactions. Therapeutic drug monitoring of digoxin is necessary due to its narrow therapeutic range. Linezolid can cause variable exposures in patients hospitalized in the intensive care unit owing to its possibility of drug-drug interactions. We present a patient with pneumonia and heart failure who experienced a possible drug interaction between linezolid and digoxin, resulting in high serum concentrations of both drugs. Also, the patient developed thrombocytopenia likely related to linezolid. The linezolid dose required to maintain sufficient levels had to reduce to 50% of the usual linezolid dose. A quarter dose of the standard digoxin dose was needed. Although the underlying mechanism of the drug interaction is unclear, we recommend conducting therapeutic drug monitoring when linezolid and digoxin are administered concurrently.
药物相互作用会导致临床效应改变,包括不良反应。由于地高辛的治疗窗较窄,因此有必要进行地高辛的治疗药物监测。由于存在药物相互作用的可能性,利奈唑胺可导致重症监护病房住院患者的血药浓度变化。我们报告一例患有肺炎和心力衰竭的患者,其可能发生了利奈唑胺和地高辛之间的药物相互作用,导致两种药物的血清浓度均升高。此外,该患者出现了可能与利奈唑胺相关的血小板减少症。维持足够血药浓度所需的利奈唑胺剂量不得不减至常用利奈唑胺剂量的50%。地高辛标准剂量需要四分之一。尽管药物相互作用的潜在机制尚不清楚,但我们建议在同时使用利奈唑胺和地高辛时进行治疗药物监测。